CDH1 and breast carcinoma: As shown in Table 3, 71% (22 cases) of breast carcinomas having low E-cadherin expressions showed negative or weak staining for LKB1, in contrast to 36% (10 cases) of the high expression cases (Figure 1G and H) (Figure 2C).